Important information regarding the novel coronavirus (COVID-19)

src cells1

In 2020, the Cancer Research Society is celebrating its 75th anniversary while the Quebec Breast Cancer Foundation marks its 25 years of supporting breast cancer research and the women affected with the disease. Together, the two organizations are celebrating 100 years of cancer research. To commemorate this historical milestone, the Cancer Research Society and the Quebec Breast Cancer Foundation announce the joint funding of one or more major research projects targeting metastatic breast cancer.


Total budget Maximum funding from the two organizations is $1,500,000/3 years. Additional funds from other sources, either in kind or in cash, are not required for this grant. However, if available, they could be included in a project budget to strengthen an application.

Research Priorities Projects must target metastatic breast cancer, and focus on one of the following priorities:

  1. Personalized medicine
  2. Immunotherapeutic approaches
  3. Overcoming drug resistance

Applicant Eligibility All applicants and co-applicants must hold an academic appointment at a Canadian university or accredited research institution. At least one applicant or co-applicant must be from an institution located in Quebec.

Competition Process Applicants to the 100 Years of Cancer Research competition must submit a letter of intent (LOI). The Cancer Research Society will review all LOIs for conformity and quality. Selected applicants will be invited to submit a full application. A peer review committee will rank the applications and chose the best ones.

Note All applications must be submitted in English to facilitate peer review by international reviewers.

Deadline for submitting a letter of intent May 21, 2020
Results of the letters of intent Early August 2020
Deadline for submitting a full grant application October 7, 2020
Announcement of the results December 2020
Payments to recipients begin March 2021


Forms, reports and instructions


For any questions or support

Lucille Beaudet, Ph.D., MBA, or 514-861-9227, ext 234

Toll-free: 1 888 766-2262, ext 234